Decitabine + Cedazuridine 35 mg + 100mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 35 mg + 100mg
Reference Brands: Inqovi (USA/EU)
Category: Oncology Cancer Care
Decitabine/cedazuridine is an oral fixed-dose combination used for the treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia. Cedazuridine improves oral absorption of decitabine by inhibiting its breakdown, allowing patients to receive effective decitabine therapy without injections.
Decitabine + Cedazuridine — third party manufacturing & bulk supply
Decitabine + Cedazuridine 35 mg + 100mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Decitabine + Cedazuridine is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Decitabine + Cedazuridine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Decitabine + Cedazuridine →Frequently Asked Questions
Decitabine + Cedazuridine is used for treating myelodysplastic syndromes and chronic myelomonocytic leukemia. Decitabine provides hypomethylating activity, while cedazuridine increases its oral absorption by inhibiting cytidine deaminase, allowing decitabine to achieve therapeutic systemic levels through an oral dosage.
Decitabine + Cedazuridine is made from two active components: decitabine, a DNA hypomethylating agent, and cedazuridine, an inhibitor of cytidine deaminase. Together, they enable effective oral administration of decitabine.
The trade name is Inqovi.
Inqovi is manufactured by Taiho Oncology and Astex Pharmaceuticals.
The generic name is decitabine and cedazuridine.
The brand name is Inqovi.
Decitabine + Cedazuridine is manufactured in the United States and Canada under Taiho and Astex production facilities for regulated markets.
Related Products
Tarlatamab-Dlle.
Strength:
1 mg, 10 mg
Form: Injection
Reference Brands: Imdelltra (USA), Imdylltra (EU/UK)
View Details
Ramucirumab
Strength:
100 mg/10 mL
Form: Solutions for disinfection
Reference Brands: Cyramza (USA/India)
View Details
Larotrectinib Sulfate
Strength:
25 mg, 100 mg, 20 mg/mL
Form: Capsule / Oral suspension
Reference Brands: Vitrakvi (USA/EU/LATAM)
View Details
Vemurafenib
Strength:
240 mg
Form: Tablets
Reference Brands: Zelboraf (USA/EU), Vemura (India)
View Details
Pertuzumab
Strength:
420 mg/14 mL
Form: Solution for IV infusion
Reference Brands: Perjeta (USA/EU), Pertuza (India), Herticad (India)
View DetailsQuick Response Guaranteed | Verified Suppliers
